| What You Need to Know from Last Week’s FDA Meeting on CBD |
| |
|
The FDA kicked off its CBD discussion with a public meeting last week. The agency is expected to continue enforcement discretion and step in when unsupported health claims are made.
To accelerate the timeline of appropriate regulation of CBD, some stakeholders at the meeting suggested that FDA issue guidance or an interim final rule. Some also reiterated a suggestion from former commissioner Gottlieb that FDA consider defining dose thresholds where low-dose CBD could be generally recognized as safe (GRAS) and added to the food supply and higher doses reserved for pharmaceutical applications.
Read Cowen’s full report on the meeting to learn more: Cowen - FDA Kicks Off CBD Discussion with No Regulatory Actions in Sight
|
|
| |
|
| Piedmont Lithium (NASDAQ: PLL) Announces Results from Phase 4 Drill Program |
| |
|
Piedmont Lithium (NASDAQ: PLL) announced Phase 4 drill results for 41 drill holes at its project in the world-class Carolina Tin-Spodumene Belt in North Carolina. The results are from Exploration Target areas and new properties within the Project’s Core property, and significant mineralization was encountered in 40 of the 41 holes reported.
Why It Matters: The positive results give strong confidence to expectations for the Mineral Resource update the Company expects to announce in June.
Key Quote: “We are very pleased with these interim results from Phase 4 drilling, which continue to highlight high-grade mineralization near-surface. The shallow nature of the ore body, combined with pure spodumene mineralogy, local by-product markets and exceptional infrastructure, are important factors which should position the Piedmont Lithium Project in the first quartile of the cost curve. We look forward to reporting a significant increase to our property-wide resource in June, and to reflecting that enlarged resource in an updated scoping study in July.” - Keith D. Phillips, President & CEO
The Backstory: Piedmont Lithium Limited holds a 100% interest in the Piedmont Lithium Project (“Project”) located within the world-class Carolina Tin-Spodumene Belt (“TSB”) and along trend to the Hallman Beam and Kings Mountain mines, historically providing most of the Western world’s lithium between the 1950s and the 1980s. The TSB has been described as one of the largest lithium provinces in the world and is located approximately 25 miles west of Charlotte, North Carolina. It is a premier location for development of an integrated lithium business based on its favorable geology, proven metallurgy and easy access to infrastructure, power, R&D centers for lithium and battery storage, major high-tech population centers and downstream lithium processing facilities.
Disclosure
Piedmont Lithium (NASDAQ: PLL) is a client of RedChip Companies, Inc. PLL agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services
|
|
| |
|
| Immuron (NASDAQ: IMRN) Announces Closing of Public Offering of 500,000 ADSs |
| |
|
Immuron Ltd. (NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, announced the closing of its previously announced underwritten public offering of 500,000 American Depositary Shares (“ADSs”) at a public offering price of USD$4.00 per ADS for gross proceeds of $2,000,000 (prior to deducting underwriting discounts, commissions and other estimated offering expenses). Each ADS represents forty (40) ordinary shares of Immuron. ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering.
The Backstory: Immuron’s technology platform utilizes highly specific vaccines for the generation of hyperimmune antibody-rich bovine colostrum, providing a means of antimicrobial therapy without the drawbacks of antibiotics to treat gut-mediated diseases. The Company currently markets Travelan®, which is a listed medicine on the Australian Register for Therapeutic Goods, in Australia to reduce the risk of travelers’ diarrhea.
Disclosure
Immuron Ltd. (NASDAQ: IMRN) is a client of RedChip Companies, Inc. IMRN agreed to pay RedChip Companies, Inc. a monthly cash fee for (3) months of investor awareness services.
|
|
| |
|
| Digital Ally (NASDAQ: DGLY) to Present to NASCAR Official Partners in Detroit |
| |
|
Digital Ally (NASDAQ: DGLY) a developer, manufacturer, and marketer of advanced video surveillance products for law enforcement, homeland security, and commercial applications, is pleased to announce it will present to Official NASCAR Partners during NASCAR’s Fuel for Business Council® meeting in Detroit, Michigan on Friday, June 7, 2019. Stan Ross, Chief Executive Officer, will be presenting.
Key Quote: “After very successful race sponsorships of the Digital Ally 250 and 400 at Kansas Speedway, we couldn’t be happier to present at the NASCAR Fuel for Business Council Meeting in Detroit,” said Stan Ross, CEO of Digital Ally.
Why It Matters: As a preferred technology partner of NASCAR and Partner Spotlight presenter, Digital Ally will showcase its patented video recording products to the commercial industry, including a number of Fortune 500 companies. The presentation will specifically demonstrate how companies can dramatically improve the safety and security of their most valuable assets—their people.
The Backstory: Digital Ally®, headquartered in Lenexa, KS, specializes in the design and manufacture of the highest quality video recording equipment and video analytic software. Digital Ally pushes the boundaries of technology in industries such as law enforcement, emergency management, commercial fleets, and consumer use. Digital Ally’s complete product solutions include in-car and body cameras, cloud and local management software, and automatic recording technology. These products work seamlessly together and are simple to install and operate. Digital Ally products are sold by domestic direct sales representatives and international distributors worldwide.
Disclosure
Digital Ally, Inc. (NASDAQ: DGLY) is a client of RedChip Companies, Inc. DGLY agreed to pay RedChip Companies, Inc., a monthly cash fee for four (4) months of RedChip investor awareness services.
|
|
| |
|
| Nemaura Medical (NASDAQ: NMRD) Receives CE Mark Approval for SugarBEAT |
| |
|
Nemaura Medical (NASDAQ: NMRD) has officially received CE Mark approval for its continuous glucose monitor (CGM) device, SugarBEAT.
Why It Matters: The device is the first non-invasive CGM that is also free of needles. It is made up of a disposable skin patch that connects to a rechargeable transmitter. Thanks to the CE Mark approval, the company will now be able to sell the device throughout the European Union.
Key Quote: “As a daily disposable adhesive skin-patch that sits on the surface of the skin, SugarBEAT is painless, and versatile in terms of wear time. Given these benefits, we look forward to aggressively entering both the multi-billion-dollar diabetic (insulin and non-insulin dependent) and pre-diabetic markets.” Dr. Faz Chowdhury, CEO
What’s Next: Following the CE Mark approval, the company said it remains on pace to submit its application to the US Food and Drug Administration (FDA) sometime in mid-2019, while its product lunch in the United Kingdom and Germany is planned for Q3.
|
|
| |
|
| ReWalk Robotics (NASDAQ: RWLK) Receives CE Mark for ReStore™ Exo-Suit Stroke Rehabilitation Device |
| |
|
ReWalk Robotics, Ltd. (NASDAQ: RWLK), a manufacturer of robotic medical devices for individuals with lower limb disabilities, announced that the ReStore Exo-Suit for stroke rehabilitation has received CE marking, clearing it for sale to rehabilitation clinics in the European Union. This CE Mark is the first clearance of a soft exo-suit, a next generation medical device which can serve a larger and more diverse patient population facing mobility challenges.
Key Quote: “The ReStore revolutionizes post stroke gait training, providing key advantage to clinics, therapists and patients.” ReWalk CEO Larry Jasinski
The Backstory: ReWalk Robotics Ltd. develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk's mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel, and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
|
|
| |
|
| Emerald Health Therapeutics (OTCQX: EMHTF) Reports Triple-Digit Revenue Growth in Q1 |
| |
|
Emerald Health Therapeutics (OTCQX: EMHTF) generated $2.6 million in sales in the first quarter ended March 31, 2019, up 131% over the December 2018 quarter and up a staggering 600% over the first quarter of 2018.
Key Quote: “Our Q1 sales demonstrate the Company’s accelerating growth in the market. As this trend continues, our team is well-positioned to create significantly increasing sales for the Company. The introduction of SYNC 25, our Emerald-branded high-CBD oil for the recreational market, demonstrates our ability to advance differentiated, innovative products to serve the marketplace.” Dr. Avtar Dhillon, President and Executive Chairman
The Backstory: Emerald produces and sells its SYNC 25 CBD oil in the adult-use market and other high-CBD products in the medical market in Canada and has sourced hemp to produce allowable oils in the current Canadian legal framework. It is also employing advanced formulation and delivery technology with the goal to offer customers new product choices in conjunction with new Canadian legislation that is expected to allow a broader set of ingestible and topical products in the fall of 2019 and beyond.
|
|
| |
|
| |
| Quote of the Week |
| |
"If you want to invest in the microcap space buy companies not stocks, if you buy stocks, the daily fluctuations and lack of liquidity will drive you crazy."
- Byron Roth, CEO ROTH Capital |
|
|
|
|
|
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures. |
|
| |
|
|
| |
|
|
Copyright © 2019 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
|
|
|
|
|
